PRIMARY BILIARY CIRRHOSIS
Clinical trials for PRIMARY BILIARY CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CIRRHOSIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Long-Term liver disease control
Disease control OngoingThis study is following 500 people with primary biliary cholangitis (PBC), a chronic liver disease, to see how safe and effective the drug seladelpar is over a long period. The main goal is to check for side effects, but researchers will also see if the drug helps control the dis…
Matched conditions: PRIMARY BILIARY CIRRHOSIS
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug trial offers hope for liver disease patients
Disease control OngoingThis study is testing a drug called elafibranor for adults with primary biliary cholangitis (PBC), a serious liver disease, who don't get enough benefit from the standard medication. The main goal is to see if the drug improves key liver blood tests and reduces symptoms like seve…
Matched conditions: PRIMARY BILIARY CIRRHOSIS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Feb 27, 2026 15:05 UTC